Cite
HARVARD Citation
Cattaruzza, F. et al. (n.d.). 613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP). Journal for immunotherapy of cancer. pp. A368-A369. [Online].